About
Oral Care Probiotics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSoutheastern U.S.
Team (11)
Alan Dunton, M.D.
Director
Oragenics
team_member
Bruce Cassidy
Director
Oragenics
team_member
Charles L. Pope
Chairman of the Board & Executive Chairman
Oragenics
board_chair
Frederick W. Telling
Director
Oragenics
team_member
James P
Chief Medical Officer
Oragenics
executive
Janet Huffman
Chief Executive Officer & Chief Financial Officer
Oragenics
executive
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
288
By Phase
PHASE2: 2NA: 1
By Status
NOT_YET_RECRUITING: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06870240Lead Sponsor
A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury
PHASE2Not yet recruiting
40 participants
Started: Jun 1, 2025 · Completed: Mar 31, 2026
NCT03234465Lead Sponsor
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
PHASE2Terminated
200 participants
Started: Jul 18, 2017 · Completed: Jul 13, 2020
NCT01520974Lead Sponsor
Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)
NAUnknown
48 participants
Started: Jan 31, 2012
Locations (1)
Headquarters
Sarasota, FL, United States
Map
Loading map...